- EFA launches #ShowLeadership campaign
- Living with allergies and airways diseases has become a daily burden for over 200 million people in Europe. The drastic increase of people living with allergy, asthma and COPD has overwhelmed European ...
- WHO urges stronger action to reduce deaths from Non-Communicable diseases in Europe
- On April 9th and 10th, the World Health Organisation (WHO) held a High-Level Conference on Non Communicable Diseases (NCDs) in Turkmenistan. The discussions were focused on national actions to reduce ...
- Delivering patient value discussed at EU Parliament
- To mark the 13th European Patients’ Rights Day, EFA attended the conference on ‘Delivering patient value throughout the healthcare system’ organised in the European Parliament by the Active Citizenshi ...
- EU Coalition for Vaccination unites for confidence
- The first meeting of the ‘EU Coalition for Vaccination’, convened by the European Commission Directorate General on Health and Food Safety (DG SANTE) united student and healthcare professional organis ...
- NAAF launches allergy and asthma podcast
- EFA Member Atma- og Allergiforbundet (NAAF) has initiated a podcast series to talk about allergies and asthma. Podcasts are emissions that can be directly listened live by subscribers or downloaded as ...
- Allergia-, Iho- ja astmaliitto celebrates 50th anniversary
- EFA Member Allergia-, Iho- ja astmaliitto (Finnish Allergy, Skin and Asthma Federation) celebrates this year its 50th anniversary and has therefore developed an interactive website showing the hi ...
- Save the Date: FENAER’s first online congress for respiratory patients
- EFA Spanish Member Federacion Española de Asociaciones de pacientes alergicos y con Enfermedades Respiratorias (FENAER) will hold its first online Congress next 8th of June. The Satellite event for pe ...
- Allergy and respiratory patients present a European campaign calling for action for better care and prevention
- On March 20th, the European Parliament Interest Group on Allergy and Asthma organised the last policy meeting of the current mandate, aimed at renewing the EU policy agenda on allergy and airways dise ...
- EFA patient leaders make our Annual General Meeting 2019 in Brussels a success
- On March 19th and 20th EFA celebrated the Annual General Meeting (AGM) of Members in Brussels, Belgium and launched the EFA annual report 2018, Shedding Light into the Severity of Allergy and Airways ...
- European Parliament Interest Group on Allergy and Asthma launches a Blueprint
- On 20th March, the European Parliament Interest Group on Allergy and Asthma, co-run by EFA and EAACI, organised at the European Parliament a Breakfast Policy Meeting on a renewed EU policy agenda on a ...
- First guidance on new rules for certain medical devices by European Medical Agency
- The European Medicines Agency (EMA) has published a first set of guidelines to help prepare for obligations coming from the new EU legislation on medical devices. The guidelines, formatted as a questi ...
- Falsified medicines: New rules to enhance patients' safety
- Falsified medicines are fake medicines that are dispensed as real, authorised, medicines. In reality, falsified medicines may contain inactive molecules, or active ingredients which are of low quality ...
- European Parliament supports the adoption of an Indoor Air Quality Performance Certificate
- On March 13th, the European Parliament plenary adopted the motion for a resolution ‘Clean Air for All: A Europe that Protects’, an initiative put forward by seven Members of the European Parliament &n ...
- EPF: EuropeforPatients campaign
- The European Patients Forum (EPF), of which EFA is a long-standing member, has launched a campaign ahead of the EU elections called ‘europeforpatients’. EPF and their Members are calling on political ...
- EFA continues to be the only patient organisation working with European Chemicals Agency
- The European Chemicals Agency (ECHA) organised its annual Accredited Stakeholder Workshop on 21 March 2019 in Brussels to mainly discuss ECHA’s Strategic Plan 2019-2023 with official stakeholders, lik ...
- New IMI Project: 3TR
- Despite the wide availability of treatments for autoimmune, inflammatory and allergic diseases, the response to therapy and the disease progression is unpredictable and varies from patient to patient. ...
- Asthma UK: Stop unfair asthma prescription charges
- EFA Member Asthma UK has launched a petition to stop unfair asthma prescription charges. By now, some 55,000 people have already signed and supported the initiative! Click here if you want to suppor ...
- European Commission Manual for patients: Patients’ rights to accessing healthcare
- The European Commission Directorate General for Health and Food Safety (DG SANTE) has published a manual for patients regarding their rights to access healthcare in any EU/EEA country different from t ...
- Rare diseases: A new platform to support better diagnosis and treatment
- In light of the Rare Disease Day in February, the European Commission has launched a new online knowledge-sharing platform to support better diagnosis and treatment for more than 30 million Europeans ...
- Asthma Allergy Denmark: Hay-fever and allergy high-school 2019
- EFA Member Astma Allergi Denmark organises a Hay-fever and Allergy High School. During the event, attendees can ask questions and get advice from Astma-Allergy Denmark. The goal of the ‘High School’ i ...